PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 49 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,797 | +16.7% | 41,148 | +16.2% | 0.00% | 0.0% |
| Q2 2023 | $178,102 | +495.9% | 35,408 | +628.6% | 0.00% | – |
| Q1 2023 | $29,889 | -76.7% | 4,860 | -49.9% | 0.00% | – |
| Q4 2022 | $128,027 | – | 9,699 | +9599.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 100 | -75.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 400 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 400 | +33.3% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 300 | +50.0% | 0.00% | – |
| Q3 2021 | $3,000 | – | 200 | +700.0% | 0.00% | – |
| Q1 2021 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 25 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
| Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
| Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
| INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
| REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
| Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
| tru Independence LLC | 500 | $0 | 0.00% |
| Renaissance Technologies | 120,269 | $319,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
| VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |